Neurogene Inc.

NGNE chart

Neurogene Inc. news

• Neurogene at Guggenheim healthcare conference: Rett gene therapy advances By Investing.com

  Investing.com Nigeria · Nov 10, 1:08 PM EST

• HC Wainwright & Co. maintains Neurogene at Buy, lowers price target to $60 from $65

  TradingView · Nov 10, 7:12 AM EST

• Neurogene Reports $94.4M Net Loss for First Nine Months Ending September 2026

  Kalkine Media · Nov 9, 4:12 PM EST

• Neurogene Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026

  www.marketscreener.com · Nov 9, 4:03 PM EST

• Neurogene Releases Q3 2026 Financial Results

  AlphaStreet · Nov 9, 2:30 PM EST

• Neurogene 3Q Loss/Shr $1.05 >NGNE

  Moomoo · Nov 9, 12:03 PM EST

• Form 8K Neurogene Inc For: 9 November By Investing.com

  Investing.com India · Nov 9, 8:50 AM EST

• Neurogene (NGNE) Beats Q3 EPS Estimates, J.P. Morgan Initiates O

  GuruFocus · Nov 9, 8:32 AM EST

• Neurogene Q3 Results: Loss narrows to $1.05 per share vs estimate

  scanx.trade · Nov 9, 8:30 AM EST

• Neurogene Reports $29.0 Million Quarterly Net Loss; Cash Runway Into Q1 2029

  TradingView · Nov 9, 8:23 AM EST

• Neurogene: Q3 Earnings Snapshot

  Yahoo Finance · Nov 9, 7:35 AM EST

• BRIEF-Neurogene Q3 Operating Income USD -32.376 Million

  TradingView · Nov 9, 7:31 AM EST

Neurogene Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-11-09
• 8-K8-K2026-11-09
• 10-Q10-Q2026-08-11
• 8-K8-K2026-08-11
• 8-K8-K2026-07-02
• 8-K8-K2026-06-29
• 8-K8-K2026-06-08
• 8-K8-K2026-06-04
• 8-K8-K2026-05-12
• 10-Q10-Q2026-05-12
• 8-K8-K2026-04-20
• DEF 14ADEF 14A2026-04-16

About Neurogene Inc.

Ticker

NGNE (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

New York, NY

Fiscal year end

December 31

SEC CIK

1404644

Former names

Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC

Frequently asked questions